Member Info for Topprize

Excellent investment… here we go build up for trial results.

Seems to be lots more focus to get a treatment out there ASAP for Covid patients who suffer from diabetes. 43,000 cases of this in India and could spread. Come on SGS let’s have the results!!

The normally rare infection, mucormycosis, has a 50% mortality rate and is hitting recovering Covid-19 patients.

This is mainly with diabetic patients.

The soon SGS treatment is out there the better for so many around the world.
https://www.bbc.co.uk/news/world-asia-india-57897682?at_medium=custom7&at_custom4=02D14920-EA22-11EB-AA28-289296E8478F&at_custom3=BBC+News&at_custom1=%5Bpost+type%5D&at_custom2=facebook_page&at_campaign=64&fbclid=IwAR0F8Lvgf0wbLgECxec6dgfBj4YM1w6jMK-lHOKUBa15CwTF6ZpQrSJvF00

To be expected as we get closer to news… only £70k

Agree Unclejim said this a while ago…. JN will no doubt know exactly what the 2 million will be used for…. He would want that amount making money rather than sat there… it seems to make sense why he hasn’t mentioned what is in the pipeline like he has done in the past… could be due to price sensitivity if he says he is investing in the production then it gives the green light that the trial is a success. We will no doubt find out soon.

Seems to be the same amount of buyers as well…
Also the whole market Has dropped today…. Nothing to worry about… believe news will come before end of August but that’s just a feeling… oh abs hope ;-)

Also another exciting point is The following….. this is going to be very big… for me this is pointing towards successful trial!!

Another area investigated during the trial, which could be attractive if the data proves it, is the possible up-regulation of T-reg cell activity which could be shown from plasma analysis of those receiving the drug. This could promote long term immunity beyond the normal life of a vaccine.

In an upbeat earnings report today (April 30 2021), Anglo-Swedish drugmaker AstraZeneca reported $275 million in revenue from its Covid-19 vaccine in the first three months of the year.

Of course the treatment is going to be profitable SGS have had multiple investors inc ourselves and the Middle East… we are an investment company and will want a return on our investment. JN has not invested in SGS just for the good of the people he will want a huge return on the success of the trial.

With 10m isolating…

Two million people could contract Covid this summer, potentially meaning up to 10 million must isolate in just six weeks, Guardian analysis shows, prompting warnings over risks to health and disruption to the economy.
The figures come as Sajid Javid, the health secretary, said England was entering “uncharted territory” in its wholesale scrapping of lockdown rules from 19 July. New infections could easily rise above 100,000 a day over the summer, he said, more than at any point in the pandemic.

The Guardian

Tbh I don’t really care where the official news comes from…. Just want it soon….

‘ Professor Sir Chris Evans brought together the scientific intellectual property, international funding and a world leading team to drive the project forward. The idea of investigating AZD1656 in this setting was conceived by Professor John Martin, of University College London and his research team at St George Street. The drug was originally developed for another indication by AstraZeneca.’

SGS also stated they will release initial results before the final…. The Final report will be to
Clinical approvers… We are not far away from knowing gla

I didn’t say statisticians publicise the results that is obviously SGS as they are in charge of the trial! The report will be completed by SGS no doubt Prof Chris
Evans as part of the team to confirm all results…
There is lots of info out there on how clinical trials work.

SGS have all the results from all the hospitals that were involved in Europe. All patient data inc placebo results need to be analysed by clinical statisticians. The results have to be analysed and collated into a full report… however as they are collating all the results for the full report they will report on initial findings to its investors. The final report will be for clinical approvers.

Looks like you should stay a mystery... not sure why anyone would invest in something they see as zero value... nowt as strange as folk!!

And yes we all know it was Estimated... all suggestions of results in any share is estimated. We were just getting excited at the prospects of it being end of June... we know nothing else better to do than wait... or moan for some!! The results will come on an RNS Through Vela first then SGS and Prof Chris website... but here first. When we don’t know.

**** feet up twiddling thumbs ****

The first we will see will be an RNS from Vela re news update on Trial. This is what has happened in the past followed by SGS tweeting it... Prof Chris company hasn’t released anything on this recently. If a tweet or post on a website comes before an RNS then they will be in breech of releasing news that is price sensitive. The only way is RNS!!

Even though we are pinning our hopes we will get a rns today, it could very well come later in the week or next week as it was only estimated to be end of June. Just have to remind ourselves of that. However really hope for today as the wait is unbearable gla

Thinking same Blue panther... it’s not really done much to today’s price... although dated today could well be from Friday...

Bit of an anticlimax this morning but we should definitely have update before Thursday.... so only 3 more sleepless nights lol

Hate having to wish the hours away... but only 8 hrs to a potential RNS that could change this company forever.... could be AAA mk2...

Gla